Back to search

Article

An Engineered Human-Antibody Fragment with Fentanyl Pan-Specificity that Reverses Carfentanil-Induced Respiratory Depression

2023-07-04

Abstract excerpt

<h4>ABSTRACT</h4> The opioid overdose crisis primarily driven by potent synthetic opioids resulted in more than 500,000 deaths in the US over the last 20 years. Though naloxone, a short acting medication, remains the primary treatment option for temporarily reversing opioid overdose effects, alternative countermeasures are needed. Monoclonal antibodies present a versatile therapeutic opportunity that can be tailo...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
84c907a4-889e-591b-acc7-bea4c3a207c9
DOI
10.1101/2023.07.04.547721
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
An Engineered Human-Antibody Fragment with Fentanyl Pan-Specificity that Reverses Carfentanil-Induced Respiratory DepressionDOI 10.1101/2023.07.04.547721
Select a neighboring publication to make it the new centre.